These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6355247)

  • 1. A double-blind histamine placebo-controlled trial of polymerized whole grass for immunotherapy of grass allergy.
    Grammer LC; Shaughnessy MA; Suszko IM; Shaughnessy JJ; Patterson R
    J Allergy Clin Immunol; 1983 Nov; 72(5 Pt 1):448-53. PubMed ID: 6355247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind placebo-controlled trial of polymerized whole grass administered in an accelerated dosage schedule for immunotherapy of grass pollinosis.
    Grammer LC; Shaughnessy MA; Finkle SM; Shaughnessy JJ; Patterson R
    J Allergy Clin Immunol; 1986 Dec; 78(6):1180-4. PubMed ID: 3537093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, placebo-controlled trial of polymerized whole ragweed for immunotherapy of ragweed allergy.
    Grammer LC; Zeiss CR; Suszko IM; Shaughnessy MA; Patterson R
    J Allergy Clin Immunol; 1982 Jun; 69(6):494-9. PubMed ID: 7042799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.
    Reich K; Gessner C; Kroker A; Schwab JA; Pohl W; Villesen H; Wüstenberg E; Emminger W
    Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term immunotherapy: a prospective, randomized, double-blind, placebo-controlled multicenter study of molecular standardized grass and rye allergens in patients with grass pollen-induced allergic rhinitis.
    Zenner HP; Baumgarten C; Rasp G; Fuchs T; Kunkel G; Hauswald B; Ring J; Effendy I; Behrendt W; Frosch PJ; Przybilla B; Brunner FX; Merk HF; Kapp A; Schnitker J; Wolf H
    J Allergy Clin Immunol; 1997 Jul; 100(1):23-9. PubMed ID: 9257783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose sublingual immunotherapy with single-dose aqueous grass pollen extract in children is effective and safe: a double-blind, placebo-controlled study.
    Wahn U; Klimek L; Ploszczuk A; Adelt T; Sandner B; Trebas-Pietras E; Eberle P; Bufe A;
    J Allergy Clin Immunol; 2012 Oct; 130(4):886-93.e5. PubMed ID: 22939758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of microencapsulated timothy grass pollen extract in grass-allergic individuals.
    TePas EC; Hoyte EG; McIntire JJ; Umetsu DT
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):25-31. PubMed ID: 14756461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. II. Comparison between parameters assessing the efficacy of immunotherapy.
    Bousquet J; Maasch H; Martinot B; Hejjaoui A; Wahl R; Michel FB
    J Allergy Clin Immunol; 1988 Sep; 82(3 Pt 1):439-46. PubMed ID: 3170992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic effect and tolerability of intra-seasonal subcutaneous immunotherapy with an 8-day up-dosing schedule to 10,000 standardized quality-units: a double-blind, randomized, placebo-controlled trial.
    Pfaar O; Wolf H; Klimek L; Schnitker J; Wüstenberg E
    Clin Ther; 2012 Oct; 34(10):2072-81. PubMed ID: 23063373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study.
    Bufe A; Ziegler-Kirbach E; Stoeckmann E; Heidemann P; Gehlhar K; Holland-Letz T; Braun W
    Allergy; 2004 May; 59(5):498-504. PubMed ID: 15080830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo and in vitro immunological changes induced by a short course of grass allergy immunotherapy tablets.
    Panizo C; Cimarra M; González-Mancebo E; Vega A; Senent C; Martín S
    J Investig Allergol Clin Immunol; 2010; 20(6):454-62. PubMed ID: 21243928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Grass pollen sublingual immunotherapy: a double-blind, placebo-controlled study in elderly patients with seasonal allergic rhinitis.
    Bozek A; Kolodziejczyk K; Warkocka-Szoltysek B; Jarzab J
    Am J Rhinol Allergy; 2014; 28(5):423-7. PubMed ID: 25198030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety and activity of polymerized ragweed: a double-blind, placebo-controlled trial in 81 patients with ragweed rhinitis.
    Grammer LC; Shaughnessy MA; Bernhard MI; Finkle SM; Pyle HR; Silvestri L; Patterson R
    J Allergy Clin Immunol; 1987 Aug; 80(2):177-83. PubMed ID: 3301986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunological changes during sublingual immunotherapy with standardized quality grass allergen tablets.
    Malling HJ; Lund L; Ipsen H; Poulsen L
    J Investig Allergol Clin Immunol; 2006; 16(3):162-8. PubMed ID: 16784009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-seasonal, subcutaneous immunotherapy: a double-blinded, placebo-controlled study in elderly patients with an allergy to grass.
    Bozek A; Kolodziejczyk K; Krajewska-Wojtys A; Jarzab J
    Ann Allergy Asthma Immunol; 2016 Feb; 116(2):156-61. PubMed ID: 26815709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and immunogenicity of immunotherapy with accelerated dosage schedules of polymerized grass and ragweed in patients with dual inhalant sensitivity.
    Grammer LC; Shaughnessy MA; Shaughnessy JJ; Patterson R
    J Allergy Clin Immunol; 1989 Apr; 83(4):750-6. PubMed ID: 2708735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of efficacy after a brief course of polymerized ragweed allergen: a controlled study.
    Grammer LC; Shaughnessy MA; Suszko IM; Shaughnessy JJ; Patterson R
    J Allergy Clin Immunol; 1984 Apr; 73(4):484-9. PubMed ID: 6707391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local intranasal immunotherapy for grass-allergic rhinitis.
    Georgitis JW; Reisman RE; Clayton WF; Mueller UR; Wypych JI; Arbesman CE
    J Allergy Clin Immunol; 1983 Jan; 71(1 Pt 1):71-6. PubMed ID: 6337198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both sublingual and supralingual routes of administration are effective in long-term allergen-specific immunotherapy.
    Panzner P; Petráš M; Sýkora T; Lesná IK; Liška M
    Allergy Asthma Proc; 2011; 32(2):142-50. PubMed ID: 21439167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin E and G antibody profiles to grass pollen allergens during a short course of sublingual immunotherapy.
    Aberer W; Hawranek T; Reider N; Schuster C; Sturm G; Kränke B
    J Investig Allergol Clin Immunol; 2007; 17(3):131-6. PubMed ID: 17583098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.